Identification of Molecular Biomarkers to Stratify Patients With Refractory Asthma

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

110 participants

Study Classification

OBSERVATIONAL

Study Start Date

2012-01-31

Study Completion Date

2016-06-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of this study is to learn more about asthma in people who are not well-controlled with current asthma medication (refractory asthma). The investigators will compare data from refractory asthmatic patients here at National Jewish Health to mild asthmatics subjects and to people without asthma. Study experiments involve looking at samples from all 3 groups and comparing them at a molecular level. These laboratory experiments may help identify subtypes of refractory asthmatics that require different treatments.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Study of TNFR:Fc (Enbrel) in the Treatment of Asthma

NCT00001893

Asthma

COMPLETED PHASE2

Comparison Of Molecular Targets In Mild To Severe Asthmatics And Healthy Subjects

NCT00331058

Asthma

TERMINATED PHASE1

Levels of Serum Resistin in Asthmatics as a Potential Marker of Systemic Inflammation and Disease State.

NCT00339703

Asthma

COMPLETED

Biomarkers in Exhaled Breath From Asthmatic Patients

NCT00635271

Asthma

TERMINATED

Role of microRNAs in T Cell-Driven Inflammation in Asthma

NCT01484691

Asthma

COMPLETED NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Asthma

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_CONTROL

Study Time Perspective

PROSPECTIVE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Able to receive Informed Consent
* At least 18 years of age
* ICS \< 880 mcg (FP equivalents)
* PC20\<=16 mg/mL
* No more than 1 oral steroid bursts in previous 12 months
* Less that 3 urgent care visit in previous 12 months
* No deterioration with \<=25% decrease in steroids
* No near fatal asthma event

Exclusion Criteria

* Pregnancy
* Current smoker, smoking within the past year or pack/year history \>10 years
* Respiratory infection within past 6 weeks
* Antibiotics within the past 6 weeks
* Active lung disease other than asthma
* Cancer within past 5 years (excluding basal cell skin cancer)
* Active or chronic infection
* Hematological or autoimmune disease
* Unable to safely undergo bronchoscopy as determined by doctor or study doctor

Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes